BioSpace News Archive

Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.

Dyno Therapeutics is a VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.

Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.

Elucida Oncology, Inc., is a clinical-stage biotechnology company pioneering the next frontier in targeted cancer therapy with its first-in-class, ultra-small nanoparticle C’Dot drug conjugate (CDC) platform.

AltruBio is developing first-in-class immune-modulators targeting diseases of #immunology and #inflammation. Its world-class global team brings a breadth of expertise in immunology and drug development that will help advance their biologic treatments to patients.

Developing next generation technologies for precision medicine and drug discovery.

Cirius Therapeutics is a clinical-stage pharmaceutical company developing innovative therapies for diseases caused by insulin resistance including Type 2 Diabetes, the metabolic consequences of Obesity, and MASLD/MASH

A commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs.

We develop clinically driven, first-in-class, tissue-specific therapeutics from human diseased tissue to treat specific fibrotic disease populations.

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in the U.S., is the clinic network of Inception - a company whose mission is to shift the paradigm of the fertility market by raising the standard of care, streamlining fragmented components into an integrated system and enhancing the overall patient experience.